1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Liu, G.
Eletsky, A.
Atreya, H.S.
Aramini, J.M.
Xiao, R.
Acton, T.
Montelione, G.T.
Szyperski, T.
Northeast Structural Genomics Consortium (NESG)
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
NE
J.STRUCT.FUNCT.GENOM.
1345-711X
10
127
136
10.1007/s10969-008-9054-7
19101823
NMR and X-RAY structures of human E2-like ubiquitin-fold modifier conjugating enzyme 1 (UFC1) reveal structural and functional conservation in the metazoan UFM1-UBA5-UFC1 ubiquination pathway.
2009
10.2210/pdb2k07/pdb
pdb_00002k07
20557.549
Ufm1-conjugating enzyme 1
1
man
polymer
Ubiquitin-fold modifier-conjugating enzyme 1
no
no
MADEATRRVVSEIPVLKTNAGPRDRELWVQRLKEEYQSLIRYVENNKNADNDWFRLESNKEGTRWFGKCWYIHDLLKYEF
DIEFDIPITYPTTAPEIAVPELDGKTAKMYRGGKICLTDHFKPLWARNVPKFGLAHLMALGLGPWLAVEIPDLIQKGVIQ
HKEKCNQLEHHHHHH
MADEATRRVVSEIPVLKTNAGPRDRELWVQRLKEEYQSLIRYVENNKNADNDWFRLESNKEGTRWFGKCWYIHDLLKYEF
DIEFDIPITYPTTAPEIAVPELDGKTAKMYRGGKICLTDHFKPLWARNVPKFGLAHLMALGLGPWLAVEIPDLIQKGVIQ
HKEKCNQLEHHHHHH
A
HR41
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
UFC1
9606
Homo sapiens
469008
Escherichia coli BL21(DE3)
BL21(DE3)
Plasmid
pET21
Northeast Structural Genomics Consortium
NESG
PSI, Protein Structure Initiative
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Database references
Derived calculations
1
0
2008-02-19
1
1
2011-07-13
1
2
2022-03-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
2008-02-19
SPRSDE
Y
BMRB
Y
RCSB
2008-01-25
REL
REL
target function
100
20
2D 1H-15N HSQC
SIMULTANEOUS HETERONUCLEAR RESOLVED [1H,1H]-NOESY
GFT (4,3)D HNNCABCA
GFT (4,3)D CABCA(CO)NHN
GFT (4,3)D HABCAB(CO)NHN
GFT (4,3) HCCH
1.1
mM
[U-100% 13C; U-100% 15N]
na
6.5
ambient
298
K
molecular dynamics, simulated annealing, distance geometry, torsion angle dynamics
1
lowest energy
1.1 mM [U-100% 13C; U-100% 15N] protein UFC1, 95% H2O/5% D2O
95% H2O/5% D2O
Brunger, Adams, Clore, Gros, Nilges and Read
refinement
CNS
1.1
Guntert, Mumenthaler and Wuthrich
refinement
CYANA
2.1
Guntert, Mumenthaler and Wuthrich
structure solution
CYANA
2.1
Guntert, Mumenthaler and Wuthrich
data analysis
CYANA
2.1
Huang, Tejero, Powers and Montelione
data analysis
AutoStructure
2.2.1
Huang, Tejero, Powers and Montelione
peak picking
AutoStructure
2.2.1
Zimmerman, Moseley, Kulikowski and Montelione
chemical shift assignment
AutoAssign
2.1
Zimmerman, Moseley, Kulikowski and Montelione
data analysis
AutoAssign
2.1
Bartels et al.
chemical shift assignment
XEASY
1.3.1.3
Bartels et al.
data analysis
XEASY
1.3.1.3
Bartels et al.
peak picking
XEASY
1.3.1.3
Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
processing
NMRPipe
2.3
Varian
collection
VNMR
750
Varian
INOVA
Varian INOVA
600
Varian
INOVA
Varian INOVA
MET
1
n
1
MET
1
A
ALA
2
n
2
ALA
2
A
ASP
3
n
3
ASP
3
A
GLU
4
n
4
GLU
4
A
ALA
5
n
5
ALA
5
A
THR
6
n
6
THR
6
A
ARG
7
n
7
ARG
7
A
ARG
8
n
8
ARG
8
A
VAL
9
n
9
VAL
9
A
VAL
10
n
10
VAL
10
A
SER
11
n
11
SER
11
A
GLU
12
n
12
GLU
12
A
ILE
13
n
13
ILE
13
A
PRO
14
n
14
PRO
14
A
VAL
15
n
15
VAL
15
A
LEU
16
n
16
LEU
16
A
LYS
17
n
17
LYS
17
A
THR
18
n
18
THR
18
A
ASN
19
n
19
ASN
19
A
ALA
20
n
20
ALA
20
A
GLY
21
n
21
GLY
21
A
PRO
22
n
22
PRO
22
A
ARG
23
n
23
ARG
23
A
ASP
24
n
24
ASP
24
A
ARG
25
n
25
ARG
25
A
GLU
26
n
26
GLU
26
A
LEU
27
n
27
LEU
27
A
TRP
28
n
28
TRP
28
A
VAL
29
n
29
VAL
29
A
GLN
30
n
30
GLN
30
A
ARG
31
n
31
ARG
31
A
LEU
32
n
32
LEU
32
A
LYS
33
n
33
LYS
33
A
GLU
34
n
34
GLU
34
A
GLU
35
n
35
GLU
35
A
TYR
36
n
36
TYR
36
A
GLN
37
n
37
GLN
37
A
SER
38
n
38
SER
38
A
LEU
39
n
39
LEU
39
A
ILE
40
n
40
ILE
40
A
ARG
41
n
41
ARG
41
A
TYR
42
n
42
TYR
42
A
VAL
43
n
43
VAL
43
A
GLU
44
n
44
GLU
44
A
ASN
45
n
45
ASN
45
A
ASN
46
n
46
ASN
46
A
LYS
47
n
47
LYS
47
A
ASN
48
n
48
ASN
48
A
ALA
49
n
49
ALA
49
A
ASP
50
n
50
ASP
50
A
ASN
51
n
51
ASN
51
A
ASP
52
n
52
ASP
52
A
TRP
53
n
53
TRP
53
A
PHE
54
n
54
PHE
54
A
ARG
55
n
55
ARG
55
A
LEU
56
n
56
LEU
56
A
GLU
57
n
57
GLU
57
A
SER
58
n
58
SER
58
A
ASN
59
n
59
ASN
59
A
LYS
60
n
60
LYS
60
A
GLU
61
n
61
GLU
61
A
GLY
62
n
62
GLY
62
A
THR
63
n
63
THR
63
A
ARG
64
n
64
ARG
64
A
TRP
65
n
65
TRP
65
A
PHE
66
n
66
PHE
66
A
GLY
67
n
67
GLY
67
A
LYS
68
n
68
LYS
68
A
CYS
69
n
69
CYS
69
A
TRP
70
n
70
TRP
70
A
TYR
71
n
71
TYR
71
A
ILE
72
n
72
ILE
72
A
HIS
73
n
73
HIS
73
A
ASP
74
n
74
ASP
74
A
LEU
75
n
75
LEU
75
A
LEU
76
n
76
LEU
76
A
LYS
77
n
77
LYS
77
A
TYR
78
n
78
TYR
78
A
GLU
79
n
79
GLU
79
A
PHE
80
n
80
PHE
80
A
ASP
81
n
81
ASP
81
A
ILE
82
n
82
ILE
82
A
GLU
83
n
83
GLU
83
A
PHE
84
n
84
PHE
84
A
ASP
85
n
85
ASP
85
A
ILE
86
n
86
ILE
86
A
PRO
87
n
87
PRO
87
A
ILE
88
n
88
ILE
88
A
THR
89
n
89
THR
89
A
TYR
90
n
90
TYR
90
A
PRO
91
n
91
PRO
91
A
THR
92
n
92
THR
92
A
THR
93
n
93
THR
93
A
ALA
94
n
94
ALA
94
A
PRO
95
n
95
PRO
95
A
GLU
96
n
96
GLU
96
A
ILE
97
n
97
ILE
97
A
ALA
98
n
98
ALA
98
A
VAL
99
n
99
VAL
99
A
PRO
100
n
100
PRO
100
A
GLU
101
n
101
GLU
101
A
LEU
102
n
102
LEU
102
A
ASP
103
n
103
ASP
103
A
GLY
104
n
104
GLY
104
A
LYS
105
n
105
LYS
105
A
THR
106
n
106
THR
106
A
ALA
107
n
107
ALA
107
A
LYS
108
n
108
LYS
108
A
MET
109
n
109
MET
109
A
TYR
110
n
110
TYR
110
A
ARG
111
n
111
ARG
111
A
GLY
112
n
112
GLY
112
A
GLY
113
n
113
GLY
113
A
LYS
114
n
114
LYS
114
A
ILE
115
n
115
ILE
115
A
CYS
116
n
116
CYS
116
A
LEU
117
n
117
LEU
117
A
THR
118
n
118
THR
118
A
ASP
119
n
119
ASP
119
A
HIS
120
n
120
HIS
120
A
PHE
121
n
121
PHE
121
A
LYS
122
n
122
LYS
122
A
PRO
123
n
123
PRO
123
A
LEU
124
n
124
LEU
124
A
TRP
125
n
125
TRP
125
A
ALA
126
n
126
ALA
126
A
ARG
127
n
127
ARG
127
A
ASN
128
n
128
ASN
128
A
VAL
129
n
129
VAL
129
A
PRO
130
n
130
PRO
130
A
LYS
131
n
131
LYS
131
A
PHE
132
n
132
PHE
132
A
GLY
133
n
133
GLY
133
A
LEU
134
n
134
LEU
134
A
ALA
135
n
135
ALA
135
A
HIS
136
n
136
HIS
136
A
LEU
137
n
137
LEU
137
A
MET
138
n
138
MET
138
A
ALA
139
n
139
ALA
139
A
LEU
140
n
140
LEU
140
A
GLY
141
n
141
GLY
141
A
LEU
142
n
142
LEU
142
A
GLY
143
n
143
GLY
143
A
PRO
144
n
144
PRO
144
A
TRP
145
n
145
TRP
145
A
LEU
146
n
146
LEU
146
A
ALA
147
n
147
ALA
147
A
VAL
148
n
148
VAL
148
A
GLU
149
n
149
GLU
149
A
ILE
150
n
150
ILE
150
A
PRO
151
n
151
PRO
151
A
ASP
152
n
152
ASP
152
A
LEU
153
n
153
LEU
153
A
ILE
154
n
154
ILE
154
A
GLN
155
n
155
GLN
155
A
LYS
156
n
156
LYS
156
A
GLY
157
n
157
GLY
157
A
VAL
158
n
158
VAL
158
A
ILE
159
n
159
ILE
159
A
GLN
160
n
160
GLN
160
A
HIS
161
n
161
HIS
161
A
LYS
162
n
162
LYS
162
A
GLU
163
n
163
GLU
163
A
LYS
164
n
164
LYS
164
A
CYS
165
n
165
CYS
165
A
ASN
166
n
166
ASN
166
A
GLN
167
n
167
GLN
167
A
LEU
168
n
168
LEU
168
A
GLU
169
n
169
GLU
169
A
HIS
170
n
170
HIS
170
A
HIS
171
n
171
HIS
171
A
HIS
172
n
172
HIS
172
A
HIS
173
n
173
HIS
173
A
HIS
174
n
174
HIS
174
A
HIS
175
n
175
HIS
175
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
GLU
57
A
N
GLU
57
A
O
PHE
66
A
O
PHE
66
A
N
CYS
69
A
N
CYS
69
A
O
PHE
80
A
O
PHE
80
1
A
A
HZ1
OE1
LYS
GLU
164
169
1.60
2
A
A
OE1
HZ2
GLU
LYS
96
114
1.60
2
A
A
OD2
HZ2
ASP
LYS
152
156
1.60
3
A
A
HB2
HB2
TRP
PHE
65
84
1.31
4
A
A
OD1
HZ3
ASP
LYS
85
114
1.56
4
A
A
HZ1
OE2
LYS
GLU
17
34
1.57
6
A
A
HB2
HB2
TRP
PHE
65
84
1.34
7
A
A
HZ2
OD1
LYS
ASP
47
52
1.58
7
A
A
HZ1
OE1
LYS
GLU
17
34
1.60
9
A
A
OE2
HZ2
GLU
LYS
96
114
1.60
11
A
A
OD2
HZ3
ASP
LYS
74
164
1.55
14
A
A
HD22
HB3
LEU
GLU
16
35
1.33
15
A
A
HB2
HD3
GLU
LYS
96
114
1.30
16
A
A
OE1
HE2
GLU
HIS
79
161
1.60
17
A
A
OE2
HG
GLU
CYS
163
165
1.55
17
A
A
HZ2
OE1
LYS
GLU
162
163
1.59
20
A
A
HZ2
OE2
LYS
GLU
77
79
1.57
1
A
ALA
2
-102.73
-161.02
1
A
ASN
19
46.25
81.13
1
A
TRP
53
-104.94
-68.69
1
A
ASP
74
68.30
-85.95
1
A
PRO
130
-96.72
-120.08
1
A
HIS
161
-152.24
41.41
1
A
CYS
165
-137.82
-43.23
1
A
ASN
166
59.68
95.04
1
A
GLN
167
72.49
-29.98
1
A
LEU
168
-60.61
-71.00
1
A
GLU
169
-84.76
-75.31
1
A
HIS
172
-64.68
93.61
1
A
HIS
173
-172.65
99.07
2
A
PRO
14
-45.52
151.20
2
A
LEU
75
72.65
-38.64
2
A
THR
89
-83.19
40.50
2
A
ILE
97
65.95
116.24
2
A
LYS
108
-96.19
35.81
2
A
PRO
130
-89.05
-153.33
2
A
HIS
161
-67.44
95.78
3
A
ASP
3
58.40
73.16
3
A
LEU
75
75.36
-20.03
3
A
ASP
103
-50.86
109.64
3
A
LYS
108
75.31
-29.56
3
A
PRO
130
-93.36
-152.88
3
A
LYS
131
77.21
-5.96
4
A
LEU
75
70.11
-0.60
4
A
ARG
111
-156.49
82.18
4
A
PRO
130
-90.43
-147.55
4
A
LYS
162
-135.96
-158.05
5
A
ALA
20
-140.45
-65.50
5
A
ASN
51
-118.39
72.96
5
A
ARG
111
-66.60
84.14
5
A
PRO
130
-89.98
-158.25
5
A
CYS
165
55.13
87.03
6
A
TRP
53
-88.79
-78.78
6
A
LEU
75
71.92
-4.89
6
A
PRO
130
-84.29
-159.47
6
A
LYS
162
-102.25
-71.56
6
A
LYS
164
-99.97
-79.01
7
A
ALA
2
-118.30
-156.00
7
A
PRO
22
-69.29
2.39
7
A
PHE
66
-152.36
86.06
7
A
LEU
75
74.46
-33.43
7
A
TYR
110
64.17
95.55
7
A
PRO
130
-95.98
-154.70
7
A
CYS
165
-95.39
50.74
7
A
GLN
167
-178.90
135.91
8
A
ALA
107
-66.99
-154.80
8
A
GLN
160
-59.88
105.10
8
A
GLU
163
61.88
60.95
8
A
CYS
165
59.61
102.14
8
A
ASN
166
-102.62
-62.93
9
A
VAL
99
63.52
86.58
9
A
LYS
108
-166.15
-168.49
9
A
MET
109
69.51
100.10
9
A
ASN
128
-105.16
70.53
9
A
PRO
130
-87.92
-139.83
9
A
LYS
131
75.54
-7.62
9
A
GLU
163
67.62
89.67
9
A
GLN
167
-59.40
100.54
9
A
HIS
171
-35.98
108.83
9
A
HIS
172
-136.69
-37.27
10
A
ALA
2
147.03
-20.20
10
A
TRP
53
-143.33
-0.25
10
A
PRO
130
-77.61
-164.65
10
A
LYS
131
73.66
-9.87
10
A
GLU
163
-50.50
109.08
10
A
GLN
167
-80.56
49.44
11
A
ALA
20
-136.08
-58.08
11
A
ALA
98
-96.98
-78.00
11
A
VAL
99
51.69
75.79
11
A
ALA
107
71.70
-35.23
11
A
PRO
130
-81.92
-132.45
11
A
LYS
131
70.34
-45.00
11
A
GLN
167
-69.83
90.27
12
A
LEU
75
75.40
-6.95
12
A
ALA
98
-95.38
-62.72
12
A
VAL
99
60.39
83.15
12
A
ASP
103
-59.89
92.62
12
A
ALA
107
-160.47
-164.08
12
A
PRO
130
-86.35
-158.30
12
A
LYS
131
75.77
-0.55
12
A
HIS
161
-171.80
127.51
13
A
ASP
3
52.09
79.46
13
A
ASN
51
-114.08
76.62
13
A
LEU
75
71.84
-3.75
13
A
ASP
103
-69.29
89.32
13
A
ALA
107
-170.70
-168.13
13
A
MET
109
65.63
98.69
13
A
ARG
111
-120.01
-81.50
13
A
PRO
130
-81.48
-152.38
13
A
LYS
131
76.02
-20.67
13
A
CYS
165
61.85
86.20
14
A
ASP
74
67.65
-85.80
14
A
ARG
111
50.32
16.02
14
A
LEU
117
-81.90
-82.20
14
A
PRO
130
-95.60
-146.19
15
A
THR
18
-68.32
97.17
15
A
ALA
20
-146.97
-37.39
15
A
ASP
74
48.08
74.07
15
A
LEU
75
72.65
-33.52
15
A
PRO
130
-85.03
-149.64
15
A
LYS
164
-126.82
-76.10
16
A
PRO
14
-49.30
151.99
16
A
THR
18
-66.13
-74.80
16
A
ALA
20
-81.59
-84.49
16
A
ASP
74
66.83
62.93
16
A
LEU
75
68.57
-13.12
16
A
ASP
103
-58.75
106.39
16
A
TYR
110
-109.22
-72.99
16
A
PRO
130
-79.12
-163.07
16
A
LYS
131
72.81
-18.53
17
A
ASP
3
70.34
135.15
17
A
ASN
51
-112.87
60.15
17
A
LEU
117
-77.65
-80.40
17
A
PRO
130
-97.11
-142.25
17
A
GLN
160
75.32
80.26
17
A
LYS
162
179.47
162.50
18
A
PRO
14
-49.99
151.22
18
A
ALA
20
-159.07
-55.17
18
A
ASP
74
64.44
-85.02
18
A
ALA
98
-92.62
-74.81
18
A
VAL
99
61.49
82.38
18
A
ARG
111
72.38
-50.18
18
A
PRO
130
-86.51
-146.61
18
A
LYS
131
72.89
-37.61
18
A
GLU
149
-141.81
11.16
18
A
LYS
162
-77.21
-82.41
18
A
CYS
165
70.13
-13.21
19
A
ALA
2
-89.83
40.55
19
A
LEU
75
73.34
-22.46
19
A
THR
106
-108.27
-164.74
19
A
ASN
166
-75.85
29.25
20
A
PRO
22
-67.15
3.32
20
A
ASP
74
64.53
-85.95
20
A
LYS
105
-133.85
-38.00
20
A
ALA
107
-74.10
-154.32
20
A
ARG
111
-51.85
109.47
20
A
PRO
130
-88.59
-151.64
20
A
LYS
131
75.24
36.66
20
A
CYS
165
-68.72
95.55
Solution NMR structure of human E2-like ubiquitin-fold modifier conjugating enzyme 1 (UFC1). Northeast Structural Genomics Consortium target HR41
1
N
N
A
ASP
3
A
ASP
3
HELX_P
A
GLU
12
A
GLU
12
1
1
10
A
ASP
24
A
ASP
24
HELX_P
A
ALA
49
A
ALA
49
1
2
26
A
HIS
120
A
HIS
120
HELX_P
A
VAL
129
A
VAL
129
1
3
10
A
GLY
133
A
GLY
133
HELX_P
A
GLY
141
A
GLY
141
1
4
9
A
GLY
141
A
GLY
141
HELX_P
A
LYS
156
A
LYS
156
1
5
16
STRUCTURAL GENOMICS, UNKNOWN FUNCTION
Ufc1, Ubiquitin Conjugating Enzyme, E2, Ufm1, Polymorphism, Ubl conjugation pathway, Structural Genomics, PSI-2, Protein Structure Initiative, Northeast Structural Genomics Consortium, NESG, UNKNOWN FUNCTION
A
TYR
90
A
TYR
90
1
A
PRO
91
A
PRO
91
3.72
A
VAL
129
A
VAL
129
1
A
PRO
130
A
PRO
130
2.67
A
TYR
90
A
TYR
90
2
A
PRO
91
A
PRO
91
-2.23
A
VAL
129
A
VAL
129
2
A
PRO
130
A
PRO
130
1.02
A
TYR
90
A
TYR
90
3
A
PRO
91
A
PRO
91
0.16
A
VAL
129
A
VAL
129
3
A
PRO
130
A
PRO
130
2.21
A
TYR
90
A
TYR
90
4
A
PRO
91
A
PRO
91
-1.25
A
VAL
129
A
VAL
129
4
A
PRO
130
A
PRO
130
5.78
A
TYR
90
A
TYR
90
5
A
PRO
91
A
PRO
91
2.13
A
VAL
129
A
VAL
129
5
A
PRO
130
A
PRO
130
-0.20
A
TYR
90
A
TYR
90
6
A
PRO
91
A
PRO
91
1.12
A
VAL
129
A
VAL
129
6
A
PRO
130
A
PRO
130
6.49
A
TYR
90
A
TYR
90
7
A
PRO
91
A
PRO
91
0.59
A
VAL
129
A
VAL
129
7
A
PRO
130
A
PRO
130
1.87
A
TYR
90
A
TYR
90
8
A
PRO
91
A
PRO
91
-0.13
A
VAL
129
A
VAL
129
8
A
PRO
130
A
PRO
130
3.88
A
TYR
90
A
TYR
90
9
A
PRO
91
A
PRO
91
1.53
A
VAL
129
A
VAL
129
9
A
PRO
130
A
PRO
130
1.03
A
TYR
90
A
TYR
90
10
A
PRO
91
A
PRO
91
-2.68
A
VAL
129
A
VAL
129
10
A
PRO
130
A
PRO
130
7.17
A
TYR
90
A
TYR
90
11
A
PRO
91
A
PRO
91
1.06
A
VAL
129
A
VAL
129
11
A
PRO
130
A
PRO
130
4.14
A
TYR
90
A
TYR
90
12
A
PRO
91
A
PRO
91
0.37
A
VAL
129
A
VAL
129
12
A
PRO
130
A
PRO
130
0.19
A
TYR
90
A
TYR
90
13
A
PRO
91
A
PRO
91
-0.10
A
VAL
129
A
VAL
129
13
A
PRO
130
A
PRO
130
3.11
A
TYR
90
A
TYR
90
14
A
PRO
91
A
PRO
91
-1.33
A
VAL
129
A
VAL
129
14
A
PRO
130
A
PRO
130
5.13
A
TYR
90
A
TYR
90
15
A
PRO
91
A
PRO
91
1.83
A
VAL
129
A
VAL
129
15
A
PRO
130
A
PRO
130
1.69
A
TYR
90
A
TYR
90
16
A
PRO
91
A
PRO
91
0.64
A
VAL
129
A
VAL
129
16
A
PRO
130
A
PRO
130
2.09
A
TYR
90
A
TYR
90
17
A
PRO
91
A
PRO
91
2.71
A
VAL
129
A
VAL
129
17
A
PRO
130
A
PRO
130
4.53
A
TYR
90
A
TYR
90
18
A
PRO
91
A
PRO
91
-1.13
A
VAL
129
A
VAL
129
18
A
PRO
130
A
PRO
130
5.87
A
TYR
90
A
TYR
90
19
A
PRO
91
A
PRO
91
2.54
A
VAL
129
A
VAL
129
19
A
PRO
130
A
PRO
130
4.23
A
TYR
90
A
TYR
90
20
A
PRO
91
A
PRO
91
1.15
A
VAL
129
A
VAL
129
20
A
PRO
130
A
PRO
130
6.45
UFC1_HUMAN
UNP
1
1
Q9Y3C8
MADEATRRVVSEIPVLKTNAGPRDRELWVQRLKEEYQSLIRYVENNKNADNDWFRLESNKEGTRWFGKCWYIHDLLKYEF
DIEFDIPITYPTTAPEIAVPELDGKTAKMYRGGKICLTDHFKPLWARNVPKFGLAHLMALGLGPWLAVEIPDLIQKGVIQ
HKEKCNQ
1
167
2K07
1
167
Q9Y3C8
A
1
1
167
1
expression tag
LEU
168
2K07
A
Q9Y3C8
UNP
168
1
expression tag
GLU
169
2K07
A
Q9Y3C8
UNP
169
1
expression tag
HIS
170
2K07
A
Q9Y3C8
UNP
170
1
expression tag
HIS
171
2K07
A
Q9Y3C8
UNP
171
1
expression tag
HIS
172
2K07
A
Q9Y3C8
UNP
172
1
expression tag
HIS
173
2K07
A
Q9Y3C8
UNP
173
1
expression tag
HIS
174
2K07
A
Q9Y3C8
UNP
174
1
expression tag
HIS
175
2K07
A
Q9Y3C8
UNP
175
3
anti-parallel
anti-parallel
A
PHE
54
A
PHE
54
A
SER
58
A
SER
58
A
ARG
64
A
ARG
64
A
HIS
73
A
HIS
73
A
LEU
76
A
LEU
76
A
ASP
85
A
ASP
85